worldpharmanews / Submitted

Novo Nordisk has announced that it will provide diabetes care, including free insulin, to 10,000 children in some of the world's poorest countries. The five-year programme, called 'Changing the Fut read more »
Discuss   Add this link to...  Bury
Researchers in Ireland and the UK have found that a lethal fungus, Aspergillus fumigatus, reproduces sexually. The findings represent a major breakthrough in the understanding of this pathogen, which read more »
Discuss   Add this link to...  Bury
Italian researchers have bred mice that exhibit similar deficits to those experienced by people with Creutzfeldt-Jakob disease, a prion disease similar to bovine spongiform encephalopathy. The EU-fun read more »
Discuss   Add this link to...  Bury
Roche and Memory Pharmaceuticals have announced that the two companies have signed a definitive merger agreement for Roche to fully acquire Memory in an all-cash transaction at a price of approximate read more »
Discuss   Add this link to...  Bury
April 27-28, 2009, Munich, Germany.
eyeforpharma's leading eMarketing Summit returns for it's forth successful year with a new format and new concepts for 2009, you'll hear from the most experien read more »
Discuss   Add this link to...  Bury
The U.S. Food and Drug Administration (FDA) has granted SELZENTRY™ (maraviroc) full (traditional) approval for use in treatment-experienced adults with CCR5-tropic HIV-1 in combination with other ant read more »
Discuss   Add this link to...  Bury
AstraZeneca has entered into a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA. read more »
Discuss   Add this link to...  Bury
Sandoz has received a positive opinion from European regulators for its third biosimilar medicine, filgrastim, marking another important milestone in its efforts to bring affordable high-quality biop read more »
Discuss   Add this link to...  Bury
Johnson & Johnson (NYSE: JNJ) and Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI), a fully integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, have an read more »
Discuss   Add this link to...  Bury
GlaxoSmithKline (GSK) has signed an exclusive Cooperation Agreement with Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (NIBT) as a preliminary step in forming a Joint Venture (JV) between the tw read more »
Discuss   Add this link to...  Bury